Business
Nutriband Inc. to Present at the Emerging Growth Conference on May 25
Nutriband Inc. Invites Individual and Institutional Investors As Well as Advisors and Analysts, To Attend Its Real-Time, Interactive Presentation at the
About this update from Nutriband Inc.
[{"type":"text","content":"Nutriband Inc. Invites Individual and Institutional Investors As Well as Advisors and Analysts, To Attend Its Real-Time, Interactive Presentation at the Emerging Growth ConferenceORLANDO, FL / ACCESSWIRE / May 20, 2022 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), is pleased to announce that it has been invited to present at the Emerging Growth Conference on May 25, 2022.This live, interactive online event will give existing shareholders and the investment community the opportunity to interact with the Company's CEO, Gareth Sheridan, in real time.Mr. Sheridan will provide a presentation and may subsequently open the floor for questions. Please ask your questions during the event and Mr. Sheridan will do his best to get through as many of them as possible.Nutriband Inc. will be presenting at 2:00 p.m. Eastern time May 25, 2022, for 30 minutes.Please register here: https://goto.webcasts.com/starthere.jsp?ei=1541770&tp_key=bb5f3aef5f&sti=ntrb to ensure you are able to attend the conference and receive any updates that are released.If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available on EmergingGrowth.com and we will also release a link to that after the event.About the Emerging Growth ConferenceThe Emerging Growth conference is an effective way for public companies to present and communicate their new products, services and other major announcements to the investment community from the convenience of their office, in a time efficient manner.The Conference focus and coverage includes companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long term growth. Its audience includes potentially tens of thousands of Individual and Institutional investors, as well as Investment advisors and analysts.All sessions will be conducted through video webcasts and will take place in the Eastern time zone.About Nutriband Inc.Nutriband Inc. is primarily engaged in the development of a portfolio of transdermal pharmaceutical products. Our lead product under development is an abuse deterrent fentanyl patch incorporating our AVERSA™ abuse deterrence technology. AVERSA™ technology may be incorporated into any transdermal patch to deter the abuse, misuse, diversion, and acc...